Diskussion zu Datametrex -- Covid19 Test Kits (Seite 339)

[boersenreportpunktcom]

Antwort auf Beitrag Nr.: 65.549.581 von investmentmoney am 30.10.20 14:32:25

Zitat von investmentmoney: Ich hab das Gefühl das läuft nicht mit richtigen Dingen zu. Nach solchen Aufträgen sollte sich der Kurs deutlich in eine andere Richtung bewegen. Die Frage ist was sind das für Kontakte ? Selbst investierte/Angestellte/Botschafter?
Momentan sind Covid-19 Tests gefragter den je. Andere Aktien schießen bei weniger bestellter Menge an Test in die Höhe und wir stützen ab!?

Meine Kontakt steht der Firma sehr nahe. Ich erhalte natürlich keine Insider Information aber diese Person kann mir erklären ob "alles" am Laufen ist. Was mich frustriert ist die absolut katastrophale Marktreaktion nach "grossen" News. Irgendwie müssen sie ihre Kommunikation und den News-Vertrieb markant verbessern. Das Problem ist dass nach positiven Pressemitteilungen die Firma nicht potenzielle Aktienkäufer anzieht. Und genau das muss sich sehr schnell ändern.

[investmentmoney]

Ich hab das Gefühl das läuft nicht mit richtigen Dingen zu. Nach solchen Aufträgen sollte sich der Kurs deutlich in eine andere Richtung bewegen. Die Frage ist was sind das für Kontakte ? Selbst investierte/Angestellte/Botschafter?
Momentan sind Covid-19 Tests gefragter den je. Andere Aktien schießen bei weniger bestellter Menge an Test in die Höhe und wir stützen ab!?

[boersenreportpunktcom]

Antwort auf Beitrag Nr.: 65.372.715 von Trashi am 13.10.20 17:13:15

Zitat von Trashi: Was sagen deine "Kontakte" in Kanada denn?

Hallo Trashi,

Mein Kontakt in Kanada ist genauso frustriert mit dem Aktienkurs wie ich. Das Geschäft mit den Covid Test Kits läuft hervorragend und die Umsätze steigen stetig an.

Ich glaube fest daran, dass das Unternehmen weitere Aufträge bekommen wird. Der Aktienkurs wird sich früher oder später in die richtige Richtung bewegen. Ich habe unter $0.10 in Kanada weitere Stücke eingesammelt.

[jd062020]

News :

Currently, supplying COVID-19 Tests for thirteen film productions launched in Vancouver, with additions in Montreal, and Toronto.

Currently executing over 4000 tests per week.

Top-line revenue estimates from the current work is approx. $20 million.

Toronto, Ontario--(Newsfile Corp. - October 27, 2020) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the "Company" or "Datametrex") is pleased to update its shareholders on the growth of film and television production COVID TESTING. As Film and Television studios continue to expand productions throughout Canada, Datametrex is being requested by its current clients to take on more coronavirus testing for their portfolio of productions across the country.

The Company has also been approached by additional film and studio companies for Datametrex to assist with fulfilling the studio with their own testing needs. Based on these current contracts, and additional opportunities for testing services which the Company is pursuing and in discussions for, management believes that the Company is on track to achieve approximately 4,000 tests per week, based on current operations Datametrex, current cost and revenue model, would result in revenue of approximately $20 million over the next 28 weeks. There can be no assurance or guarantee that this revenue amount will result for the Company.

The global film and video market is expected to decline from $252.9 billion in 2019 to $244.4 billion in 2020 at a compound annual growth rate (CAGR) of -3.4%. The decline is mainly due to economic slowdown across countries owing to the COVID-19 outbreak and the measures to contain it. The market is then expected to recover and grow at a CAGR of 5% from 2021 and reach $284 billion in 2023.

(https://www.businesswire.com/news/home/20200821005370/en/Glo…

Marshal Gunter, CEO, said, "I must first say thank you to the entire team at Datametrex along with the medical and lab professionals for their tireless work at the company. We are ramping up our business to meet increasing demand and our expectation based on what we are seeing in the market is to execute on approximately 10,000 tests per week on a progressive basis. We are witnessing a paradigm shift within the film industry. With the advent of movie theaters being closed in numerous regions around the globe due to government enforced shut downs by coronavirus, film and television companies rely more on at-home streaming services to maintain a robust revenue model. Content production is key to this and Canada is a major platform for content development. The demand remains high for qualified medical professionals from the private sector to be on site, and in the lab, ensuring complete and timely delivery of coronavirus tests supplied by Datametrex." He continued, "with our growing revenue model, we remain committed to our shareholders and will announce further developments with additional conference calls and press releases in the coming weeks."

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex's mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter - CEO
Phone: [phone]
Email: [e-mail]

Neither the TSX Venture Exchange nor it's Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain "forward-looking information" or constitute "forward-looking statements" within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management's current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy, including the dollar amount of revenue anticipated as disclosed in this press release.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

[jd062020]

https://finance.yahoo.com/news/datametrex-expands-distributi…

[boersenreportpunktcom]

Datametrex AI halted at 6:28 a.m. PT

2020-10-27 09:30 ET - Halt Trading


Datametrex AI Ltd. has been halted at 6:28 a.m. PT on Oct. 27, 2020, at the company's request, pending news.

[jd062020]

Any news ?

[boersenreportpunktcom]

Antwort auf Beitrag Nr.: 65.372.715 von Trashi am 13.10.20 17:13:15

Ich sollte heute oder morgen mit meinen Kontakten in Kanada nochmals reden.

[Trashi]

Was sagen deine "Kontakte" in Kanada denn?

[boersenreportpunktcom]

News betreffend AI Technologie und Covid-19

Datametrex AI Pandemic Management System Charting Hotspot Signs Of COVID-19 Outbreaks

Toronto, Ontario--(Newsfile Corp. - October 5, 2020) - Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the "Company" or "Datametrex") is pleased to announce the development of an advanced statistical model to assess the current state of the pandemic and to monitor COVID-19 hotspots using Artificial Intelligence ("AI") and Machine Learning ("ML").

Prior to the COVID-19 pandemic's stranglehold on the world, leaders increasingly embraced advanced analytics and AI, for good reason. According to a 2018 study by the McKinsey Global Institute, entitled: Notes from the AI frontier: Applications and value of deep learning, these capabilities are estimated to have the potential to create between approximately $9.5 trillion and $15.4 trillion in annual global economic value.[1]

As the COVID-19 pandemic continues to spread around the globe, the Company is further developing its Nexalogy AI to build automated tracking systems that will mine vast amounts of data using NexaIntelligence, from social media and traditional news, for signs of new COVID-19 outbreaks being discussed in real-time.

Secondly, the Company is developing an early alarm mapping system to keep watch for the pandemic using an advanced ML statistical model to monitor COVID-19 on the Lexical Map. This is developed using automatic text analysis that identifies with coloured clusters the sub-themes to understand COVID-19 noise versus signal quickly and certainly underscores the potential of AI and ML.

Predicting positive results based on scientific mapping brings new developments to treatment in which clusters are systematically screened using computer algorithms for tracking and tracing for viral testing protocols leading to any subsequent quarantining and healthcare that may well be required.

This new system will collect and analyze COVID-19 data from Twitter, Facebook, Tumblr, blogs, web forums, online news sites, Google Alerts and RSS feeds.

"Our AI pandemic management and analytics platform supports the modelling and monitoring of COVID-19. By leveraging smartphones and other digital technology, we use our analytics to produce metrics that help governments and communities evaluate trends to enable strategic and efficient deployment of resources," said Marshall Gunter, CEO of the Company.

About Datametrex

Datametrex AI Limited is a technology-focused with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex's mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain. Additional information on Datametrex is available at www.datametrex.com.

For further information, please contact:

Marshall Gunter - CEO
Phone: [phone]
Email: [e-mail]

Neither the TSX Venture Exchange nor it's Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

Certain statements including in this news release contain "forward-looking information" or constitute "forward-looking statements" within the meaning of applicable securities laws. Such forward-looking statements or information are provided for the purpose of providing information about management's current expectations and plans relating to the future. Readers are cautioned that reliance on such information may not be appropriate for other purposes In some cases, forward-looking information can be identified by words or phrases such as "may", "will", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen, or by discussions of strategy, including the dollar amount of revenue anticipated under the Agreement.

Forward-looking statements or information are based on current expectations, estimates and projections that involve several risks and uncertainties, which could cause actual results to differ materially from those anticipated by the Company and described in the forward-looking statements or information. These risks and uncertainties may cause actual results to differ materially from the forward-looking statements or information.

Readers are cautioned that the foregoing list is not exhaustive of all possible risks and uncertainties. Readers are also cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the time such forward-looking information is made. Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.